Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 21;20(2):260-267.
doi: 10.1002/cphc.201800624. Epub 2018 Sep 13.

A Structural Basis for 129 Xe Hyper-CEST Signal in TEM-1 β-Lactamase

Affiliations

A Structural Basis for 129 Xe Hyper-CEST Signal in TEM-1 β-Lactamase

Benjamin W Roose et al. Chemphyschem. .

Abstract

Genetically encoded (GE) contrast agents detectable by magnetic resonance imaging (MRI) enable non-invasive visualization of gene expression and cell proliferation at virtually unlimited penetration depths. Using hyperpolarized 129 Xe in combination with chemical exchange saturation transfer, an MR contrast approach known as hyper-CEST, enables ultrasensitive protein detection and biomolecular imaging. GE MRI contrast agents developed to date include nanoscale proteinaceous gas vesicles as well as the monomeric bacterial proteins TEM-1 β-lactamase (bla) and maltose binding protein (MBP). To improve understanding of hyper-CEST NMR with proteins, structural and computational studies were performed to further characterize the Xe-bla interaction. X-ray crystallography validated the location of a high-occupancy Xe binding site predicted by MD simulations, and mutagenesis experiments confirmed this Xe site as the origin of the observed CEST contrast. Structural studies and MD simulations with representative bla mutants offered additional insight regarding the relationship between local protein structure and CEST contrast.

Keywords: CEST; Xenon; contrast; hyperpolarized; magnetic resonance.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Chain A of the bla-Xe complex (PDB ID 5HW1), with Xe shown as red spheres (van der Waals radii enlarged for clarity). (Inset) Xe1 binding site, with surrounding protein side chains shown as sticks (Xe-derivative in gray, native bla in cyan). Gray dashes indicate protein-Xe contacts within 4.5 Å. Isomorphous difference Fourier map for Xe1 shown as blue mesh and contoured at 10 σ.
Figure 2.
Figure 2.
129Xe hyper-CEST z-spectra of 80 μM bla in pH 7.2 PBS at 300 K. Unliganded bla (red) compared to bla in the presence of 1 mM tazobactam (green). Z-spectrum of PBS only (gray) shown for reference. Pulse length, τpulse = 3.80 ms; field strength, B1,max = 77 μT.
Figure 3.
Figure 3.
Xe occupancy map calculated from a 1 μs trajectory (only the last 400 ns included in the map). Blue shading is the density at an arbitrary isovalue. Red spheres are Xe atoms from a representative frame of the MD trajectory. Yellow spheres are Xe atoms found in the Xe-derivative crystal structure of WT bla.
Figure 4.
Figure 4.
(a) Xe1 shown as a red sphere, with nearby side chains shown as sticks (Xe-derivative of WT bla in gray, “open” bla bound to allosteric inhibitor in magenta). (b) Number of Xe atoms in the Xe1 binding site correlated to the minimum distance between I263 and I279 side chains (minimum among all possible pairwise atom-atom distances). (c) Number of Xe atoms in the major binding site anti-correlated to the number of atom-atom contacts between I263 and I279 side chains.
Figure 5.
Figure 5.
Xe1 cavity of the Xe-derivative of WT bla, with mutated side chains highlighted in green. Closest side chain contacts to Xe1 measured in Å.
Figure 6.
Figure 6.
129Xe hyper-CEST z-spectra of 80 μM bla in pH 7.2 PBS at 300 K. Bla mutants (various colors) compared to WT bla (red). Z-spectrum of PBS only (gray) shown for reference. Pulse length, τpulse = 3.80 ms; field strength, B1,max = 77 μT.
Figure 7.
Figure 7.
Xe1 and Xe5 (red spheres) bound to bla mutants I263L (a), I263N (b), and I263A (c), with distances shown in units Å. Isomorphous difference maps corresponding to Xe shown as blue mesh and contoured at 5 σ. Simulated annealing (SA) omit maps corresponding to mutated I263L and I263N side chains shown as green mesh and contoured at 3 σ. The I263 side chain of WT bla (yellow sticks) and Xe bound to WT bla (yellow sphere) shown for reference.
Figure 8.
Figure 8.
Combined Xe1 entry and exit pathways from 1 μs MD simulations for WT bla (top-left). The thickness of each trace correlates to the number of Xe atoms following that trajectory. Blue blobs indicate average Xe density. Plots show the correlation between Xe binding and inter-side chain distances of residues 263 and 279 from MD Xe flooding simulations of bla mutants following the same parameters used for WT bla (Figs. 4b, 4c).
Scheme 1.
Scheme 1.
During hyper-CEST, exchangeable solute-bound Xe atoms that resonate at a frequency different from solution-phase hyperpolarized Xe (green) are selectively spin-flipped using RF irradiation. Rapid exchange leads to the depolarization of bulk solution-phase Xe (gray), thereby generating MR contrast.

References

    1. Palmer AE, Qin Y, Park JG, McCombs JE, Trends Biotechnol. 2011, 29, 144–152. - PMC - PubMed
    2. Contag CH, Bachmann MH, Annu. Rev. Biomed. Eng 2002, 4, 235–260. - PubMed
    3. Tsien RY, Annu. Rev. Biochem 1998, 67, 509–544. - PubMed
    4. Lippincott-Schwartz J, Patterson GH, Science. 2003, 300, 87–91. - PubMed
    5. Frommer WB, Davidson MW, Campbell RE, Chem. Soc. Rev 2009, 38, 2833–2841. - PMC - PubMed
    1. Marvin JS, Borghuis BG, Tian L, Cichon J, Harnett MT, Akerboom J, Gordus A, Renninger SL, Chen T-W, Bargmann CI, Orger MB, Schreiter ER, Demb JB, Gan W-B, Hires SA, Looger LL, Nat. Methods 2013, 10, 162–70. - PMC - PubMed
    2. Lu Y, Stem Cells Dev. 2004, 13, 133–145. - PubMed
    3. Thomas CE, Ehrhardt A, Kay MA, Nat. Rev. Genet 2003, 4, 346–358. - PubMed
    1. Guillard S, Minter RR, Jackson RH, Trends Biotechnol. 2015, 33, 163–171. - PubMed
    2. Carter PJ, Nat. Rev. Immunol 2006, 6, 343–357. - PubMed
    1. Lyons SK, Patrick PS, Brindle KM, Cold Spring Harb. Protoc 2013, 2013, 685–699. - PubMed
    2. Weissleder R, Ntziachristos V, Nat. Med 2003, 9, 123–128. - PubMed
    3. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW, Contag CH, J. Biomed. Opt 2011, 10, 41210. - PubMed
    4. Dmochowski IJ, Dmochowski JE, Oliveri P, Davidson EH and Fraser SE, Proc. Natl. Acad. Sci. U. S. A 2002, 99, 12895–12900. - PMC - PubMed
    1. Couch MJ, Blasiak B, Tomanek B, Ouriadov AV, Fox MS, Dowhos KM, Albert MS, Mol. Imaging Biol 2015, 17, 149–162. - PubMed

Publication types

LinkOut - more resources